A new App Note is now available to download entitled ‘Unlock the power of multiplexing for high-throughput single-cell analysis and isolation’. Download the Application Note to discover Cyto-Mine Chroma and picodroplet technology for advanced single-cell analysis: Multiplexing: Simultaneously detect and isolate rare secreting cells using secreted and cellular markers. Ultra-High-Throughput:… Read More
Discover Cyto-Mine® Chroma and picodroplet technology for advanced single-cell analysis: Multiplexing: Simultaneously detect and isolate rare secreting cells using secreted and cellular markers. Ultra-High-Throughput: Efficiently process and sort millions of cells with high accuracy. Cell viability: Maintain high viability and accuracy using complex assays. Download the Application Note to transform… Read More
This paid-for advertorial by Sphere Fluidics appeared in DDW Volume 25 – Issue 2, Spring 2024. Sphere Fluidics discusses how picodroplet microfluidic technology and automated single-cell analysis can help overcome barriers to accelerating biopharmaceutical discovery and cell line development workflows. Challenges in cell line development Biopharmaceutical development is a time-consuming and… Read More
This paid-for advertorial by Sphere Fluidics appeared in the SLAS 2023 Supplement, Volume 24 – Issue 1, Winter 2022/2023 Cell engineering is being held back by lengthy and complicated multi-step workflows. Sphere Fluidics’ Cyto-Mine® system offers a streamlined, automated solution to this challenge using picodroplet microfluidic technology. Cell engineering is bringing… Read More
Generation of a highly expressing, regulatory acceptable clonal cell line is the first key activity in the development of a biopharmaceutical. Cell line development is labour intensive, time consuming and costly and is subject to stringent regulations to ensure patient safety. Dr Jonathan H Dempsey All cell lines used to… Read More
Join DDW for this exclusive on-demand event Embedding Quality into Cell Line Development Through the Application of an Innovative Picodroplet-Based Single Cell Sorter, supported by Sphere Fluidics. Generation of a highly expressing, regulatory acceptable clonal cell line is the first key activity in the development of a biopharmaceutical. Cell line development… Read More
Join DDW and Sphere Fluidics for this exclusive on-demand event Embedding Quality into Cell Line Development Through the Application of an Innovative Picodroplet-Based Single Cell Sorter. Generation of a highly expressing, regulatory acceptable clonal cell line is the first key activity in the development of a biopharmaceutical. Read More
Generation of a highly expressing, regulatory acceptable clonal cell line is the first key activity in the development of a biopharmaceutical. Cell line development is labour intensive, time consuming and costly and is subject to stringent regulations to ensure patient safety. All cell lines used to produce clinical batches of… Read More
Join DDW for this exclusive on-demand event Embedding Quality into Cell Line Development Through the Application of an Innovative Picodroplet-Based Single Cell Sorter, supported by Sphere Fluidics. Generation of a highly expressing, regulatory acceptable clonal cell line is the first key activity in the development of a biopharmaceutical. Cell line development… Read More
